Abstract
Background
Introducing colonoscopy as part of colorectal cancer screening on a national level, we aimed at evaluating the efficacy of the two most common bowel cleansing agents, Moviprep® and Phosphoral®. Secondly, we evaluated the benefit for the patient and society in terms of sick leave and discomfort.
Methods
In a single-blinded randomized equivalence trial, Phosphoral® (NaP) was compared with Moviprep® (2 l polyethylene glycol + ascorbic acid) in patients undergoing colonoscopy due to suspicion of cancer. Patients filled out questionnaires concerning stool consistency, discomfort and number of sick days due to bowel cleansing. Blinded colonoscopists estimated the efficiency of the cleansing using the validated Harefield Cleansing Scale.
Results
Two hundred and sixty-six patients were included 250 of whom underwent full colonoscopy. There was no difference in the percentage of acceptable bowel cleansings in the two groups; however, a significantly higher number of A scores were observed in the Moviprep® group (p = 0.028). We found no correlation between stool consistency and outcome of the cleansing and no difference in subjective discomfort during cleansing. Vomiting during cleansing occurred more often in the Phosphoral® group (p = 0.002). There was a trend toward a smaller number of sick days in patients who used Moviprep® compared with Phosphoral®.
Conclusions
Moviprep® and Phosphoral® provided equally efficient bowel cleansing in 90 % of patients, but Moviprep® provided a higher quality of cleansings graded as successful. The two agents were equally tolerated, and no difference was found in the related number of sick days.
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs10151-014-1198-9/MediaObjects/10151_2014_1198_Fig1_HTML.gif)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs10151-014-1198-9/MediaObjects/10151_2014_1198_Fig2_HTML.gif)
Similar content being viewed by others
References
Fisker J (2010) Recommendations on screening for colorectal cancer [in Danish]. http://sundhedsstyrelsen.dk/publ/Publ2012/09sep/ScreeningTarmkraeftAnbef2udg.pdf. Last accessed 7/3/2014
Colic E, Marcussen N (2011) Acute phosphate nephropathy as a complication to bowel cleansing with oral sodium phosphate. Ugeskr Laeger 173:3270–3271
Connor A, Tolan D, Hughes S, Carr N, Tomson C (2012) Consensus guidelines for the prescription and administration of oral bowel cleansing agents. Gut 61:1525–1532
Hassan C, Bretthauer M, Kaminski MF et al (2013) Bowel preparation for colonoscopy: European Society of Gastrointestinal Endoscopy (ESGE) guideline. Endoscopy 45:142–150
Parente F, Marino B, Crosta C (2009) Bowel preparation before colonoscopy in the era of mass screening for colo-rectal cancer: a practical approach. Dig Liver Dis 41:87–95
Belsey J, Crosta C, Epstein O et al (2012) Meta-analysis: the relative efficacy of oral bowel preparations for colonoscopy 1985–2010. Aliment Pharmacol Ther 35:222–237
Juluri R, Eckert G, Imperiale TF (2011) Polyethylene glycol vs. sodium phosphate for bowel preparation: a treatment arm meta-analysis of randomized controlled trials. BMC Gastroenterol 14:38
Halphen M, Heresbach D, Gruss HJ, Belsey J (2013) Validation of the Harefield Cleansing Scale: a tool for the evaluation of bowel cleansing quality in both research and clinical practice. Gastrointest Endosc 78:121–131
Heaton KW, Radvan J, Cripps H, Mountford RA, Braddon FE, Hughes AO (1992) Defecation frequency and timing, and stool form in the general population: a prospective study. Gut 33:818–824
Aihara H, Saito S, Arakawa H et al (2009) Comparison of two sodium phosphate tablet-based regimens and a polyethylene glycol regimen for colon cleansing prior to colonoscopy: a randomized prospective pilot study. Int J Colorectal Dis 24:1023–1030
Bartoli R, Boix J, Odena G, de Vega Moreno V, Lorenzo-Zuniga V (2012) Determination of the ideal preparation for colonoscopy in a rat model. Surg Laparosc Endosc Percutan Tech 22:542–545
Bitoun A, Ponchon T, Barthet M et al (2006) Results of a prospective randomised multicentre controlled trial comparing a new 2-L ascorbic acid plus polyethylene glycol and electrolyte solution vs. sodium phosphate solution in patients undergoing elective colonoscopy. Aliment Pharmacol Ther 24:1631–1642
Clarkston WK, Tsen TN, Dies DF, Schratz CL, Vaswani SK, Bjerregaard P (1996) Oral sodium phosphate versus sulfate-free polyethylene glycol electrolyte lavage solution in outpatient preparation for colonoscopy: a prospective comparison. Gastrointest Endosc 43:42–48
Jansen SV, Goedhard JG, Winkens B, van Deursen CT (2011) Preparation before colonoscopy: a randomized controlled trial comparing different regimes. Eur J Gastroenterol Hepatol 23:897–902
Ben CN, Ben MW, Hellara O et al (2012) Bowel preparation before colonoscopy. Presse Med 41:37–42
Balaban DH, Leavell BS Jr, Oblinger MJ, Thompson WO, Bolton ND, Pambianco DJ (2003) Low volume bowel preparation for colonoscopy: randomized, endoscopist-blinded trial of liquid sodium phosphate versus tablet sodium phosphate. Am J Gastroenterol 98:827–832
Corporaal S, Kleibeuker JH, Koornstra JJ (2010) Low-volume PEG plus ascorbic acid versus high-volume PEG as bowel preparation for colonoscopy. Scand J Gastroenterol 45:1380–1386
Worthington J, Thyssen M, Chapman G, Chapman R, Geraint M (2008) A randomised controlled trial of a new 2 litre polyethylene glycol solution versus sodium picosulphate + magnesium citrate solution for bowel cleansing prior to colonoscopy. Curr Med Res Opin 24:481–488
Rodriguez De Miguel C, Serradesanferm A, Del Manzano S et al (2012) Timing of polyethylene glycol administration is a key factor in the tolerability and efficacy of colon preparation in colorectal cancer screening. Gastroenterol Hepatol 35:236–242
Repici A, Cestari R, Annese V et al (2012) Randomised clinical trial: low-volume bowel preparation for colonoscopy—a comparison between two different PEG-based formulations. Aliment Pharmacol Ther 36:717–724
Kao D, Lalor E, Sandha G et al (2011) A randomized controlled trial of four precolonoscopy bowel cleansing regimens. Can J Gastroenterol 25:657–662
Rostom A, Jolicoeur E (2004) Validation of a new scale for the assessment of bowel preparation quality. Gastrointest Endosc 59:482–486
Calderwood AH, Jacobson BC (2010) Comprehensive validation of the Boston Bowel Preparation Scale. Gastrointest Endosc 72:686–692
Di Palma J, Rex D (2011) Advances in bowel preparations: new formulation and clinical results. Gastroenterol Nurs 34(Suppl 2):S2–S8
Acknowledgments
We would like to thank the staff at the endoscopy unit at Randers Regional Hospital for contributing to this project, interviewing patients and filling in questionnaires. Also, we would like to thank the CRC coordinators for randomizing patients and distributing the agents as well as the participating doctors for evaluating the quality of the cleansing.
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Haas, S., Andersen, L.M. & Sommer, T. Randomized controlled trial comparing Moviprep® and Phosphoral® as bowel cleansing agents in patients undergoing colonoscopy. Tech Coloproctol 18, 929–935 (2014). https://doi.org/10.1007/s10151-014-1198-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10151-014-1198-9